Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 260

1.

Advances in understanding iron metabolism and its crosstalk with erythropoiesis.

Camaschella C, Pagani A.

Br J Haematol. 2018 Jun 25. doi: 10.1111/bjh.15403. [Epub ahead of print] Review.

PMID:
29938779
2.

A severe hemojuvelin mutation leading to late onset of HFE2-hemochromatosis.

Ravasi G, Pelucchi S, Mariani R, Silvestri L, Camaschella C, Piperno A.

Dig Liver Dis. 2018 Apr 27. pii: S1590-8658(18)30715-1. doi: 10.1016/j.dld.2018.04.018. [Epub ahead of print] No abstract available.

PMID:
29764732
3.

The immunophilin FKBP12 inhibits hepcidin expression by binding the BMP type I receptor ALK2 in hepatocytes.

Colucci S, Pagani A, Pettinato M, Artuso I, Nai A, Camaschella C, Silvestri L.

Blood. 2017 Nov 9;130(19):2111-2120. doi: 10.1182/blood-2017-04-780692. Epub 2017 Sep 1.

4.

Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management.

Cappellini MD, Comin-Colet J, de Francisco A, Dignass A, Doehner W, Lam CS, Macdougall IC, Rogler G, Camaschella C, Kadir R, Kassebaum NJ, Spahn DR, Taher AT, Musallam KM; IRON CORE Group.

Am J Hematol. 2017 Oct;92(10):1068-1078. doi: 10.1002/ajh.24820. Epub 2017 Jul 7. Review.

5.

A new form of IRIDA due to combined heterozygous mutations of TMPRSS6 and ACVR1A encoding the BMP receptor ALK2.

Pagani A, Colucci S, Bocciardi R, Bertamino M, Dufour C, Ravazzolo R, Silvestri L, Camaschella C.

Blood. 2017 Jun 22;129(25):3392-3395. doi: 10.1182/blood-2017-03-773481. Epub 2017 May 5. No abstract available.

6.

Clinical significance of somatic mutation in unexplained blood cytopenia.

Malcovati L, Gallì A, Travaglino E, Ambaglio I, Rizzo E, Molteni E, Elena C, Ferretti VV, Catricalà S, Bono E, Todisco G, Bianchessi A, Rumi E, Zibellini S, Pietra D, Boveri E, Camaschella C, Toniolo D, Papaemmanuil E, Ogawa S, Cazzola M.

Blood. 2017 Jun 22;129(25):3371-3378. doi: 10.1182/blood-2017-01-763425. Epub 2017 Apr 19.

7.

New insights into iron deficiency and iron deficiency anemia.

Camaschella C.

Blood Rev. 2017 Jul;31(4):225-233. doi: 10.1016/j.blre.2017.02.004. Epub 2017 Feb 13. Review.

PMID:
28216263
8.

Induction of iron excess restricts malignant plasma cells expansion and potentiates bortezomib effect in models of multiple myeloma.

Bordini J, Galvan S, Ponzoni M, Bertilaccio MT, Chesi M, Bergsagel PL, Camaschella C, Campanella A.

Leukemia. 2017 Apr;31(4):967-970. doi: 10.1038/leu.2016.346. Epub 2016 Nov 24. No abstract available.

PMID:
27881873
9.

Meta-GWAS and Meta-Analysis of Exome Array Studies Do Not Reveal Genetic Determinants of Serum Hepcidin.

Galesloot TE, Verweij N, Traglia M, Barbieri C, van Dijk F, Geurts-Moespot AJ, Girelli D, Kiemeney LA, Sweep FC, Swertz MA, van der Meer P, Camaschella C, Toniolo D, Vermeulen SH, van der Harst P, Swinkels DW.

PLoS One. 2016 Nov 15;11(11):e0166628. doi: 10.1371/journal.pone.0166628. eCollection 2016.

10.

The Repair of Skeletal Muscle Requires Iron Recycling through Macrophage Ferroportin.

Corna G, Caserta I, Monno A, Apostoli P, Manfredi AA, Camaschella C, Rovere-Querini P.

J Immunol. 2016 Sep 1;197(5):1914-25. doi: 10.4049/jimmunol.1501417. Epub 2016 Jul 27.

11.

The mutual control of iron and erythropoiesis.

Camaschella C, Pagani A, Nai A, Silvestri L.

Int J Lab Hematol. 2016 May;38 Suppl 1:20-6. doi: 10.1111/ijlh.12505. Epub 2016 May 9. Review.

PMID:
27161430
12.

Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice.

Nai A, Rubio A, Campanella A, Gourbeyre O, Artuso I, Bordini J, Gineste A, Latour C, Besson-Fournier C, Lin HY, Coppin H, Roth MP, Camaschella C, Silvestri L, Meynard D.

Blood. 2016 May 12;127(19):2327-36. doi: 10.1182/blood-2015-11-681494. Epub 2016 Jan 11.

13.

Iron deficiency: new insights into diagnosis and treatment.

Camaschella C.

Hematology Am Soc Hematol Educ Program. 2015;2015:8-13. doi: 10.1182/asheducation-2015.1.8. Review.

PMID:
26637694
14.

Ineffective erythropoiesis and regulation of iron status in iron loading anaemias.

Camaschella C, Nai A.

Br J Haematol. 2016 Feb;172(4):512-23. doi: 10.1111/bjh.13820. Epub 2015 Oct 22. Review.

PMID:
26491866
15.

Transferrin receptor 2 mutations in patients with juvenile hemochromatosis phenotype.

Ravasi G, Rausa M, Pelucchi S, Arosio C, Greni F, Mariani R, Pelloni I, Silvestri L, Pineda P, Camaschella C, Piperno A.

Am J Hematol. 2015 Dec;90(12):E226-7. doi: 10.1002/ajh.24202. Epub 2015 Nov 17. No abstract available.

16.

Comment on: PACE4 (PCSK6): another proprotein convertase linked to iron homeostasis?

Pagani A, Ladli M, Nai A, Verdier F, Camaschella C, Silvestri L.

Haematologica. 2015 Sep;100(9):e380. doi: 10.3324/haematol.2015.128348. No abstract available.

17.

Iron-Deficiency Anemia.

Camaschella C.

N Engl J Med. 2015 Jul 30;373(5):485-6. doi: 10.1056/NEJMc1507104. No abstract available.

18.

Functional Analysis of GLRX5 Mutants Reveals Distinct Functionalities of GLRX5 Protein.

Liu G, Wang Y, Anderson GJ, Camaschella C, Chang Y, Nie G.

J Cell Biochem. 2016 Jan;117(1):207-17. doi: 10.1002/jcb.25267.

PMID:
26100117
19.

Iron-deficiency anemia.

Camaschella C.

N Engl J Med. 2015 May 7;372(19):1832-43. doi: 10.1056/NEJMra1401038. Review. No abstract available.

PMID:
25946282
20.

Bmp6 expression in murine liver non parenchymal cells: a mechanism to control their high iron exporter activity and protect hepatocytes from iron overload?

Rausa M, Pagani A, Nai A, Campanella A, Gilberti ME, Apostoli P, Camaschella C, Silvestri L.

PLoS One. 2015 Apr 10;10(4):e0122696. doi: 10.1371/journal.pone.0122696. eCollection 2015.

21.

Corrigendum: Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis.

Benyamin B, Esko T, Ried JS, Radhakrishnan A, Vermeulen SH, Traglia M, Gögele M, Anderson D, Broer L, Podmore C, Luan J, Kutalik Z, Sanna S, van der Meer P, Tanaka T, Wang F, Westra HJ, Franke L, Mihailov E, Milani L, Hälldin J, Winkelmann J, Meitinger T, Thiery J, Peters A, Waldenberger M, Rendon A, Jolley J, Sambrook J, Kiemeney LA, Sweep FC, Sala CF, Schwienbacher C, Pichler I, Hui J, Demirkan A, Isaacs A, Amin N, Steri M, Waeber G, Verweij N, Powell JE, Nyholt DR, Heath AC, Madden PA, Visscher PM, Wright MJ, Montgomery GW, Martin NG, Hernandez D, Bandinelli S, van der Harst P, Uda M, Vollenweider P, Scott RA, Langenberg C, Wareham NJ, van Duijn C, Beilby J, Pramstaller PP, Hicks AA, Ouwehand WH, Oexle K, Gieger C, Metspalu A, Camaschella C, Toniolo D, Swinkels DW, Whitfield JB.

Nat Commun. 2015 Mar 30;6:6542. doi: 10.1038/ncomms7542. No abstract available.

22.

Erythroblast apoptosis and microenvironmental iron restriction trigger anemia in the VK*MYC model of multiple myeloma.

Bordini J, Bertilaccio MT, Ponzoni M, Fermo I, Chesi M, Bergsagel PL, Camaschella C, Campanella A.

Haematologica. 2015 Jun;100(6):834-841. doi: 10.3324/haematol.2014.118000. Epub 2015 Feb 24.

23.

Identification of TMPRSS6 cleavage sites of hemojuvelin.

Rausa M, Ghitti M, Pagani A, Nai A, Campanella A, Musco G, Camaschella C, Silvestri L.

J Cell Mol Med. 2015 Apr;19(4):879-88. doi: 10.1111/jcmm.12462. Epub 2015 Feb 22.

24.

Regulation of cell surface transferrin receptor-2 by iron-dependent cleavage and release of a soluble form.

Pagani A, Vieillevoye M, Nai A, Rausa M, Ladli M, Lacombe C, Mayeux P, Verdier F, Camaschella C, Silvestri L.

Haematologica. 2015 Apr;100(4):458-65. doi: 10.3324/haematol.2014.118521. Epub 2015 Jan 30.

25.

The second transferrin receptor regulates red blood cell production in mice.

Nai A, Lidonnici MR, Rausa M, Mandelli G, Pagani A, Silvestri L, Ferrari G, Camaschella C.

Blood. 2015 Feb 12;125(7):1170-9. doi: 10.1182/blood-2014-08-596254. Epub 2014 Dec 11.

26.

Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis.

Benyamin B, Esko T, Ried JS, Radhakrishnan A, Vermeulen SH, Traglia M, Gögele M, Anderson D, Broer L, Podmore C, Luan J, Kutalik Z, Sanna S, van der Meer P, Tanaka T, Wang F, Westra HJ, Franke L, Mihailov E, Milani L, Hälldin J, Winkelmann J, Meitinger T, Thiery J, Peters A, Waldenberger M, Rendon A, Jolley J, Sambrook J, Kiemeney LA, Sweep FC, Sala CF, Schwienbacher C, Pichler I, Hui J, Demirkan A, Isaacs A, Amin N, Steri M, Waeber G, Verweij N, Powell JE, Nyholt DR, Heath AC, Madden PA, Visscher PM, Wright MJ, Montgomery GW, Martin NG, Hernandez D, Bandinelli S, van der Harst P, Uda M, Vollenweider P, Scott RA, Langenberg C, Wareham NJ; InterAct Consortium, van Duijn C, Beilby J, Pramstaller PP, Hicks AA, Ouwehand WH, Oexle K, Gieger C, Metspalu A, Camaschella C, Toniolo D, Swinkels DW, Whitfield JB.

Nat Commun. 2014 Oct 29;5:4926. doi: 10.1038/ncomms5926. Erratum in: Nat Commun. 2015;6:6542. Häldin, Jonas [corrected to Hälldin, Jonas].

27.

Heterozygous missense mutations in the GLRX5 gene cause sideroblastic anemia in a Chinese patient.

Liu G, Guo S, Anderson GJ, Camaschella C, Han B, Nie G.

Blood. 2014 Oct 23;124(17):2750-1. doi: 10.1182/blood-2014-08-598508. No abstract available.

28.

Functional and clinical impact of novel TMPRSS6 variants in iron-refractory iron-deficiency anemia patients and genotype-phenotype studies.

De Falco L, Silvestri L, Kannengiesser C, Morán E, Oudin C, Rausa M, Bruno M, Aranda J, Argiles B, Yenicesu I, Falcon-Rodriguez M, Yilmaz-Keskin E, Kocak U, Beaumont C, Camaschella C, Iolascon A, Grandchamp B, Sanchez M.

Hum Mutat. 2014 Nov;35(11):1321-9. doi: 10.1002/humu.22632. Epub 2014 Sep 10.

PMID:
25156943
29.

The extrahepatic role of TFR2 in iron homeostasis.

Silvestri L, Nai A, Pagani A, Camaschella C.

Front Pharmacol. 2014 May 7;5:93. doi: 10.3389/fphar.2014.00093. eCollection 2014. Review.

30.

The erythroid function of transferrin receptor 2 revealed by Tmprss6 inactivation in different models of transferrin receptor 2 knockout mice.

Nai A, Pellegrino RM, Rausa M, Pagani A, Boero M, Silvestri L, Saglio G, Roetto A, Camaschella C.

Haematologica. 2014 Jun;99(6):1016-21. doi: 10.3324/haematol.2013.103143. Epub 2014 Mar 21.

31.

Mutation spectrum in Chinese patients affected by congenital sideroblastic anemia and a search for a genotype-phenotype relationship.

Liu G, Guo S, Kang H, Zhang F, Hu Y, Wang L, Li M, Ru Y, Camaschella C, Han B, Nie G.

Haematologica. 2013 Dec;98(12):e158-60. doi: 10.3324/haematol.2013.095513. No abstract available.

32.

Iron and hepcidin: a story of recycling and balance.

Camaschella C.

Hematology Am Soc Hematol Educ Program. 2013;2013:1-8. doi: 10.1182/asheducation-2013.1.1.

PMID:
24319154
33.

Hepcidin and ferritin blood level as noninvasive tools for predicting breast cancer.

Orlandi R, De Bortoli M, Ciniselli CM, Vaghi E, Caccia D, Garrisi V, Pizzamiglio S, Veneroni S, Bonini C, Agresti R, Daidone MG, Morelli D, Camaschella C, Verderio P, Bongarzone I.

Ann Oncol. 2014 Feb;25(2):352-7. doi: 10.1093/annonc/mdt490. Epub 2013 Dec 3.

PMID:
24306042
34.

How I treat unexplained refractory iron deficiency anemia.

Hershko C, Camaschella C.

Blood. 2014 Jan 16;123(3):326-33. doi: 10.1182/blood-2013-10-512624. Epub 2013 Nov 8.

35.

Genome wide association analysis of a founder population identified TAF3 as a gene for MCHC in humans.

Pistis G, Okonkwo SU, Traglia M, Sala C, Shin SY, Masciullo C, Buetti I, Massacane R, Mangino M, Thein SL, Spector TD, Ganesh S; CHARGE Consortium Hematology Working, Pirastu N, Gasparini P, Soranzo N, Camaschella C, Hart D, Green MR, Toniolo D.

PLoS One. 2013 Jul 31;8(7):e69206. doi: 10.1371/journal.pone.0069206. Print 2013.

36.

A strong anti-inflammatory signature revealed by liver transcription profiling of Tmprss6-/- mice.

Riba M, Rausa M, Sorosina M, Cittaro D, Garcia Manteiga JM, Nai A, Pagani A, Martinelli-Boneschi F, Stupka E, Camaschella C, Silvestri L.

PLoS One. 2013 Jul 29;8(7):e69694. doi: 10.1371/journal.pone.0069694. Print 2013.

37.

Correction: Increased Serum Hepcidin Levels in Subjects with the Metabolic Syndrome: A Population Study.

Martinelli N, Traglia M, Campostrini N, Biino G, Corbella M, Sala C, Busti F, Masciullo C, Manna D, Previtali S, Castagna A, Pistis G, Olivieri O, Toniolo D, Camaschella C, Girelli D.

PLoS One. 2013 Jun 26;8(6). doi: 10.1371/annotation/233a5ac3-8118-4bdc-a139-950223506864. Print 2013.

38.

Treating iron overload.

Camaschella C.

N Engl J Med. 2013 Jun 13;368(24):2325-7. doi: 10.1056/NEJMcibr1304338. No abstract available.

PMID:
23758239
39.

Iron refractory iron deficiency anemia.

De Falco L, Sanchez M, Silvestri L, Kannengiesser C, Muckenthaler MU, Iolascon A, Gouya L, Camaschella C, Beaumont C.

Haematologica. 2013 Jun;98(6):845-53. doi: 10.3324/haematol.2012.075515. Review.

40.

How to assess causality of TMPRSS6 mutations?

Silvestri L, Rausa M, Pagani A, Nai A, Camaschella C.

Hum Mutat. 2013 Jul;34(7):1043-5. doi: 10.1002/humu.22321. Epub 2013 Apr 17. No abstract available.

PMID:
23554218
41.

The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients: TMPRSS6 and hepcidin in hemodialysis.

Pelusi S, Girelli D, Rametta R, Campostrini N, Alfieri C, Traglia M, Dongiovanni P, Como G, Toniolo D, Camaschella C, Messa P, Fargion S, Valenti L.

BMC Nephrol. 2013 Feb 22;14:48. doi: 10.1186/1471-2369-14-48.

42.

A meta-analysis of thyroid-related traits reveals novel loci and gender-specific differences in the regulation of thyroid function.

Porcu E, Medici M, Pistis G, Volpato CB, Wilson SG, Cappola AR, Bos SD, Deelen J, den Heijer M, Freathy RM, Lahti J, Liu C, Lopez LM, Nolte IM, O'Connell JR, Tanaka T, Trompet S, Arnold A, Bandinelli S, Beekman M, Böhringer S, Brown SJ, Buckley BM, Camaschella C, de Craen AJ, Davies G, de Visser MC, Ford I, Forsen T, Frayling TM, Fugazzola L, Gögele M, Hattersley AT, Hermus AR, Hofman A, Houwing-Duistermaat JJ, Jensen RA, Kajantie E, Kloppenburg M, Lim EM, Masciullo C, Mariotti S, Minelli C, Mitchell BD, Nagaraja R, Netea-Maier RT, Palotie A, Persani L, Piras MG, Psaty BM, Räikkönen K, Richards JB, Rivadeneira F, Sala C, Sabra MM, Sattar N, Shields BM, Soranzo N, Starr JM, Stott DJ, Sweep FC, Usala G, van der Klauw MM, van Heemst D, van Mullem A, Vermeulen SH, Visser WE, Walsh JP, Westendorp RG, Widen E, Zhai G, Cucca F, Deary IJ, Eriksson JG, Ferrucci L, Fox CS, Jukema JW, Kiemeney LA, Pramstaller PP, Schlessinger D, Shuldiner AR, Slagboom EP, Uitterlinden AG, Vaidya B, Visser TJ, Wolffenbuttel BH, Meulenbelt I, Rotter JI, Spector TD, Hicks AA, Toniolo D, Sanna S, Peeters RP, Naitza S.

PLoS Genet. 2013;9(2):e1003266. doi: 10.1371/journal.pgen.1003266. Epub 2013 Feb 7.

43.

Iron increases the susceptibility of multiple myeloma cells to bortezomib.

Campanella A, Santambrogio P, Fontana F, Frenquelli M, Cenci S, Marcatti M, Sitia R, Tonon G, Camaschella C.

Haematologica. 2013 Jun;98(6):971-9. doi: 10.3324/haematol.2012.074872. Epub 2012 Dec 14.

44.

Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study.

Martinelli N, Traglia M, Campostrini N, Biino G, Corbella M, Sala C, Busti F, Masciullo C, Manna D, Previtali S, Castagna A, Pistis G, Olivieri O, Toniolo D, Camaschella C, Girelli D.

PLoS One. 2012;7(10):e48250. doi: 10.1371/journal.pone.0048250. Epub 2012 Oct 29.

45.

How I manage patients with atypical microcytic anaemia.

Camaschella C.

Br J Haematol. 2013 Jan;160(1):12-24. doi: 10.1111/bjh.12081. Epub 2012 Oct 11. Review.

PMID:
23057559
46.

Identification and characterization of the first SLC11A2 isoform 1a mutation causing a defect in splicing process and an hypomorphic allele expression of the SLC11A2 gene.

De Falco L, Bruno M, Andolfo I, David BP, Girelli D, Di Noce F, Camaschella C, Iolascon A.

Br J Haematol. 2012 Nov;159(4):492-5. doi: 10.1111/bjh.12062. Epub 2012 Sep 27. No abstract available.

PMID:
23016933
47.

Serum levels of the hepcidin-20 isoform in a large general population: the Val Borbera study.

Campostrini N, Traglia M, Martinelli N, Corbella M, Cocca M, Manna D, Castagna A, Masciullo C, Silvestri L, Olivieri O, Toniolo D, Camaschella C, Girelli D.

J Proteomics. 2012 Dec 5;76 Spec No.:28-35. doi: 10.1016/j.jprot.2012.08.006. Epub 2012 Aug 21.

48.

Deletion of TMPRSS6 attenuates the phenotype in a mouse model of β-thalassemia.

Nai A, Pagani A, Mandelli G, Lidonnici MR, Silvestri L, Ferrari G, Camaschella C.

Blood. 2012 May 24;119(21):5021-9. doi: 10.1182/blood-2012-01-401885. Epub 2012 Apr 6.

49.

TMPRSS6 rs855791 modulates hepcidin transcription in vitro and serum hepcidin levels in normal individuals.

Nai A, Pagani A, Silvestri L, Campostrini N, Corbella M, Girelli D, Traglia M, Toniolo D, Camaschella C.

Blood. 2011 Oct 20;118(16):4459-62. doi: 10.1182/blood-2011-06-364034. Epub 2011 Aug 26.

50.

Molecular mechanisms regulating hepcidin revealed by hepcidin disorders.

Camaschella C, Silvestri L.

ScientificWorldJournal. 2011 Jul 7;11:1357-66. doi: 10.1100/tsw.2011.130. Review.

Supplemental Content

Loading ...
Support Center